RecruitingNCT06718569

Pain in Inflammatory Joint Diseases

Advancing the Understanding of Pain Mechanisms in Inflammatory Arthritis Towards Precision Pain Management

Sponsor

Diakonhjemmet Hospital

Enrollment

350 participants

Start Date

Nov 11, 2025

Study Type

OBSERVATIONAL

Conditions

Arthritis Arthritis, Rheumatoid Arthritis, Psoriatic Spondyloarthritis (SpA)Arthritis, Juvenile Idiopathic Arthritis, Reactive

Summary

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Biological or targeted synthetic DMARD for people with arthritis, arthritis, juvenile idiopathic, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.